Claims for Patent: 6,080,913

Summary for Patent: 6,080,913

Title:	Binary methods of increasing accumulation of essential amino acids in seeds
Abstract:	The present invention provides methods for genetically modifying plants to increase the levels of essential amino acids in seed. The present methods involve a combination of: a) providing an increased reservoir or source of a target amino acid population in vegetative tissue; with b) a complementary protein sink.
Inventor(s):	Tarczynski; Mitchell C. (West Des Moines, IA), Staswick; Paul E. (Lincoln, NE)
Assignee:	Pioneer Hi-Bred International, Inc. (Des Moines, IA)
Application Number:	08/719,500
Patent Claims:	1. A seed-crop plant, genetically modified by the steps comprising: a) expressing a transgene in an organ or tissue of a plant other than the seed, wherein the transgene encodes an amino acid sequence enriched in a target amino acid; and b) accumulating the target amino acid in the seed to a level greater than in the wild type seed. 2. A plant according to claim 1 wherein the amino acid is selected from the group consisting of alanine, asparagine, aspartate, cysteine, glutamate, glutamine, glycine, proline, serine, tyrosine, arginine, histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine. 3. A plant according to claim 2 wherein the amino acid is selected from the group consisting of arginine, histidine, isoleucine, leucine, lysine, methionine, cysteine, phenylalanine, threonine, tryptophan and valine. 4. A plant according to claim 3 wherein the plant is selected from the group consisting of soybean, canola, corn, sunflower, wheat, barley, oats, millet, rice, sorghum and rye. 5. A plant according to claim 1 wherein the amino acid sequence is a protein. 6. A plant according to claim 5 wherein the protein is a storage protein. 7. A plant according to claim 1 wherein the first transgene is expressed in the root, leaf, stem, pod, mesophyll, palisade, cortex, bundle sheath, paraveinal mesophyll or epidermis. 8. A plant according to claim 1 wherein the expression of the transgene is under the control of a promoter selected from the group consisting of vspA, vspB, rubisco activase, ferredoxin, rubisco small subunit and chlorophyll AB binding protein. 9. A plant according to claim 1 wherein the genetic modification further comprises the step of expressing a second transgene in the seed which encodes a protein enriched in the target amino acid. 10. A plant according to claim 9 wherein the protein contains at least 20% more target amino acid than the average protein. 11. A plant according to claim 10 wherein the protein contains at least 50% more target amino acid than the average protein. 12. A plant according to claim 11 wherein the protein is a storage protein. 13. A plant according to claim 12 wherein the protein is a seed storage protein. 14. A plant according to claim 13 wherein the protein is selected from the group consisting of rice 10 kDa, 13 kDa and 16 kDa promaline; sunflower 2S albumin protein; Brazil nut 2S albumin protein; soybean seed storage protein; 10 kDa zein protein; thionin; 2S albumin from alfalfa and soybean albumin. 15. A plant according to claim 14 wherein the protein is sunflower albumin-8 or a high lysine derivative of alpha-hordothionin. 16. A plant according to claim 9 wherein the expression of the second transgene is under the control of a promoter selected from the group consisting of the .beta.-conglycinin, .beta.-phaseolin, napin, soybean lectin, maize 15 kD zein, 22 kD zein, .gamma.-zein, waxy, shrunken 1, globulin 1 and shrunken 2. 17. A plant according to claim 9 which is soybean or corn. 18. A plant according to claim 17 which is a soybean plant and the protein is sunflower albumin-8. 19. A plant according to claim 17 which is a corn plant and the protein is a high lysine derivative of alpha-hordothionin. 20. A seed produced by the plant of claim 1. 21. A seed produced by the plant of claim 9. 22. A seed produced by the plant of claim 4.

Details for Patent 6,080,913

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Genentech, Inc.	ACTIVASE	alteplase	For Injection	103172	11/13/1987		2039-02-26
Genentech, Inc.	CATHFLO ACTIVASE	alteplase	For Injection	103172	09/04/2001		2039-02-26